Travis S. Schlappi, PhD.

Travis S. Schlappi, PhD, joined the KGI Henry E. Riggs School of Applied Life Sciences in September 2017 as an Assistant Professor of Medical Diagnostics. Dr. Schlappi received his undergraduate degree from Brigham Young University in 2011 and his PhD from the California Institute of Technology in 2017, both in chemical engineering. For his PhD research, Dr. Schlappi was selected as a finalist in the National Inventors Hall of Fame Collegiate Inventors Competition and also chosen for Diagnostics World’s Early Innovator Award. His research at KGI focuses on developing medical diagnostics and therapeutics that benefit patients in limited-resource settings without access to hospitals or modern healthcare technology.

Abstract: The Role of Rapid POC Diagnostics in Public Health Emergencies

The COVID-19 pandemic is a unique public health emergency that has caused economic and societal damage in addition to millions of sicknesses of deaths. Mitigating the severity of this pandemic will require significant advancements and integrated efforts in vaccine development, public health education, personal hygiene, government aid, treatment options, and diagnostic testing. This talk will focus on the role of point-of-care (POC) diagnostics in controlling pandemics and reducing their adverse effects. Several emerging technologies for POC COVID-19 detection have recently received Emergency Use Authorization from the FDA. While these new devices will improve our response to the COVID-19 pandemic, other diagnostic technology gaps need to be addressed to more effectively respond to public health emergencies now and in the future.